Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Gilead Sciences Inc (NASDAQ:GILD)

72.11
Delayed Data
As of Aug 18
 -0.23 / -0.32%
Today’s Change
63.76
Today|||52-Week Range
82.10
+0.70%
Year-to-Date

Today’s Trading

Previous close72.34
Today’s open72.32
Day’s range71.83 - 72.63
Volume6,052,601
Average volume (3 months)8,487,674
Market cap$94.2B
Dividend yield2.88%
Data as of 4:29pm ET, 08/18/2017

Growth & Valuation

Earnings growth (last year)-16.54%
Earnings growth (this year)-25.07%
Earnings growth (next 5 years)-10.33%
Revenue growth (last year)-5.37%
P/E ratio7.8
Price/Sales3.21
Price/Book5.00

Competitors

 Today’s
change
Today’s
% change
AMGNAmgen-0.52-0.31%
BIIBBiogen-2.65-0.93%
ILMNIllumina Inc-1.88-0.98%
KITEKite Pharma Inc+4.15+3.29%
Data as of 4:00pm ET, 08/18/2017

Financials

Next reporting dateOctober 31, 2017
EPS forecast (this quarter)$2.11
Annual revenue (last year)$30.3B
Annual profit (last year)$13.5B
Net profit margin44.53%

Profile

Sector
Health Technology
Industry
Biotechnology
President, Chief Executive Officer &
Director
John F. Milligan
Chief Operating Officer
Kevin B. Young
Corporate headquarters
Foster City, California

Forecasts